Glioblastoma Multiforme Treatment Market Research Insights 2024-2030

The report "Glioblastoma Multiforme Treatment Market by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region – Global Forecasts to 2030", is projected to reach USD 2.85 billion in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 9.9% during the forecast period 2024-2030. The growth of the glioblastoma multiforme treatment market is majorly driven by the increasing prevalence of brain disorders.